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Abstract
Objective: This study focused on altered mitochondrial dynamics as a potential
mechanism for diabetic peripheral neuropathy (DPN). We employed both an
in vitro sensory neuron model and an in situ analysis of human intraepidermal
nerve fibers (IENFs) from cutaneous biopsies to measure alterations in the size
distribution of mitochondria as a result of hyperglycemia and diabetes, respec-
tively. Methods: Neurite- and nerve-specific mitochondrial signals within cul-
tured rodent sensory neurons and human IENFs were measured by employing
a three-dimensional visualization and quantification technique. Skin biopsies
from distal thigh (DT) and distal leg (DL) were analyzed from three groups of
patients; patients with diabetes and no DPN, patients with diabetes and con-
firmed DPN, and healthy controls. Results: This analysis demonstrated an
increase in mitochondria distributed within the neurites of cultured sensory
neurons exposed to hyperglycemic conditions. Similar changes were observed
within IENFs of the DT in DPN patients compared to controls. This change
was represented by a significant shift in the size frequency distribution of mito-
chondria toward larger mitochondria volumes within DT nerves of DPN
patients. There was a length-dependent difference in mitochondria within
IENFs. Distal leg IENFs from control patients had a significant shift toward
larger volumes of mitochondrial signal compared to DT IENFs. Interpretation:
The results of this study support the hypothesis that altered mitochondrial
dynamics may contribute to DPN pathogenesis. Future studies will examine the
potential mechanisms that are responsible for mitochondrial changes within
IENFs and its effect on DPN pathogenesis.
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Introduction
Diabetic peripheral neuropathy (DPN) is a common com-
plication of diabetes occurring in 60–70% of diabetic
patients. Distal symmetric sensorimotor polyneuropathy
is the most common complication of type 2 diabetes,
resulting in length-dependent injury of the longest pro-
jecting axons.1 Possible clinical presentations include
asymptomatic neuropathy, painful neuropathy, and pain-
less neuropathy with loss of protective sensation predis-
posing to foot ulceration and amputation.
Intraepidermal nerve fiber (IENF) density has become an
accepted measure of small fiber neuropathies2–7 and specific
guidelines for the use of skin biopsy in the diagnosis of small
fiber neuropathy have been established.8,9 The loss of IENFs is
associated with DPN in human diabetic patients6,10–13 and
animal models of diabetes.14–16 Importantly, there is evidence
that therapeutic intervention results in an increase in IENF
densities and an improvement in patient assessment of pain
in prediabetes associated neuropathy.17 Despite the usefulness
of IENF densities as a measure of neuropathy severity, it is
necessary to understand the underlying mechanism responsi-
ble for the loss or improvement of IENFs.
Mitochondrial dysfunction has been implicated in a
number of neurodegenerative diseases including Alzhei-
mer’s disease, amyotrophic lateral sclerosis, Charcot–
Marie–Tooth disease, Huntington’s disease, hereditary
spastic paraparesis, and optic atrophy.18–22 Notably, a
number of studies have demonstrated mitochondrial dys-
function in peripheral neuropathies including chemother-
apy- and diabetes-induced neuropathies.23–28 Studies from
our laboratory and others have identified hyperglycemia
and diabetes-induced changes in mitochondrial dynam-
ics.28–33 In particular, changes in mitochondrial fission
were observed in the neurites of sensory neurons.28,30 This
study was designed to expand the work on diabetes-
induced changes in mitochondrial dynamics. Initial experi-
ments were done in an in vitro sensory neuron model
system to examine the effects of hyperglycemia on
mitochondria distribution and develop a three-dimensional
(3D) analysis technique to measure neurite-specific mito-
chondria. The novel 3D imaging and analysis technique
was then applied to specifically examine mitochondria
within IENFs from human cutaneous biopsies in an
attempt to translate these in vitro effects to the clinically
relevant sensory nerves preferentially lost in DPN.
Materials and Methods
Sensory neuron cultures and image analysis
Timed pregnant rats were purchased from Charles River
Laboratories (Wilmington, MA). All rodent care and use
was approved and regulated by the Unit for Laboratory
Animal Medicine at the University of Michigan. Dissoci-
ated dorsal root ganglion (DRG) neurons were isolated
from E15 Sprague-Dawley rat embryos following previ-
ously published methods.34 Cultures were maintained at
37°C in a humidified atmosphere containing 5% CO2.
Neurons were used 1–2 days after plating and were trea-
ted with or without additional 20 mmol/L glucose for 6 h
to promote a hyperglycemic environment.30,35 Mitochon-
dria were visualized and imaged following previously pub-
lished methods.30
Fluorescent signals in the images were optimized by de-
convolution with Volocity software (PerkinElmer, Wal-
tham, MA) using the iterative restoration feature set at
90% confidence level and a period of 10 cycles. Mito-
chondrial signals from each image were exported from
Volocity as OME TIFF files, imported into Imaris, and
then saved as Imaris files (IMS).
The built-in surface creator in Imaris was used to cre-
ate virtual surfaces around neurites with the “background
subtraction” method to account for regional changes in
fluorescent intensity within the images. A threshold inten-
sity range was chosen specifically for each image in a way
that maximized image signal and minimized noise. A sub-
sequent filtering step allowed for the removal of noise
from the data set. A filter ranging from 5 to 40 voxels
was used for every image depending on the level of noise
in that particular image. All remaining objects were sur-
rounded by a 3D virtual surface that was used to extract
data. Values were exported from Imaris and into an Excel
spreadsheet for all nerve and mitochondrial surfaces to
generate a size distribution of mitochondrial signal.
Patient population recruitment
Three groups of patients were studied: seven patients with
diabetes and no DPN (DM), seven patients with diabetes
and confirmed DPN, and seven age-matched healthy con-
trols (Control). Study subjects were recruited from a large
community-based primary care network at the University
of Utah Diabetes Center (Salt Lake City, UT). The defini-
tion of definite neuropathy was based on the presence of
at least three of the following: symptoms of neuropathy,
signs based on an abnormal quantitative neurologic
examination, abnormality of nerve conducting studies,
quantitative sensory testing, quantitative sudomotor axon
reflex testing, and skin biopsy with measurement of intra-
epidermal nerve fiber density (IENFD). Patients included
in the analysis accounted for known differences in IEN-
FDs associated with age and gender.36 Clinical profiles for
the patients included in the study are summarized in
Table 1. Control subjects were recruited for the study that
had no prior history of diabetes or peripheral neuropathy
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and were of similar age to the other groups. All subjects
signed an informed consent. The University of Utah Insti-
tutional Review Board approved the protocol.
Human tissue collection
Each subject underwent a 3-mm skin biopsy from the dis-
tal thigh (DT) and distal leg (DL). Samples were subse-
quently preserved in paraformaldehyde lysine phosphate
for 24 h, sectioned at 50 lm, and stored in a cryoprotec-
tant solution (30% glycerin and 30% ethylene glycol in
phosphate buffered saline (PBS)).
Fluorescent immunohistochemistry
Tissue sections were pretreated with a block solution of
5% goat serum + 0.3% Triton X-100 (Sigma, St. Louis,
MO) detergent solution at room temperature for 1 h with
gentle shaking. Sections were incubated with primary
antibodies to visualize mitochondria (1:100 mouse anti-
pyruvate dehydrogenase (PDH), MitoScience, Eugene,
OR) and IENFs (1:1000 polyclonal rabbit anti-PGP-9.5,
protein gene product 9.5; AbD Serotek, Raleigh, NC) in
an incubation solution (1% goat serum + 0.3% Triton X-
100) with gentle shaking at room temperature for 1 h
then transferred to 4°C with gentle shaking overnight.
Sections were washed three times with the incubation
solution and allowed to shake for 1 h after each rinse.
Fluorescent secondary antibodies were used to visualize
mitochondria (1:1000 goat anti-mouse AlexaFluor-594;
Invitrogen, Eugene, OR) and IENFs (1:1000 goat anti-rab-
bit AlexaFluor-488; Invitrogen) with the same incubation
process used for the primary antibodies. Sections were
washed twice with 19 PBS for 5 min, followed by two
extended washes with shaking at room temperature for
30 min each, and finally transferred to freshly filtered 19
PBS. Skin sections were mounted onto glass slides using
Prolong Gold with DAPI (Invitrogen) to fluorescently
label nuclei.
Image acquisition and analysis
Slides were masked as to not influence which regions were
chosen for imaging. Images were collected with a Leica
TCS SP5 confocal microscope system (Leica Microsystems,
Inc., Buffalo Grove, IL, USA) using either a 40 9 1.25
numerical aperture (N.A.) or 63 9 1.40 N.A. (the highest
magnification and N.A. available on our Leica SP5 confo-
cal system) oil immersion objective on an inverted Leica
DMI6000 microscope. Fluorescent signals were sequen-
tially acquired at each focal plane for nuclei (excitation
k = 405 nm, spectral emission filter k = 420–480 nm),
IENFs (excitation k = 488 nm, spectral emission filter
k = 505–560 nm), and mitochondria (excitation
k = 543 nm, spectral emission filter k = 606–670 nm). Z-
series were taken through the extent of the tissue with
zoom of 1.79, frame averaging of 2, step size of 0.17 lm,
resolution of 512 9 512 pixels, and 12-bit depth. Four Z-
series from at least two different tissue sections were taken
at 409 from each biopsy site (DT and DL) for every
patient. A corresponding 639 image was collected for a
subset of the 409 images to directly compare 409 versus
639 as follows: DT: Control n = 2, DM n = 3, and DPN
n = 2; and for DL: Control n = 3, DM n = 3, and DPN
n = 2. The range and average number of nerves per image
were as follows: DT: Control range 4–10, average 5.6, DM
range 5–8, average 6.2, and DPN range 4–6, average 4.8;
DL: Control range 3–7, average 5.9, DM range 3–10, aver-
age 5.9, and DPN range 1–6, average 2.9. Z-series that had
poor mitochondria labeling were not included in the final
Table 1. Clinical profile of patient population.
Age-matched controls Diabetic patients (DM) Diabetic peripheral neuropathy patients (DPN)
N 7 7 7
Age (years) 52.8  8.7 53.1  6.3 52.3  9.3
UENS – 0.6  1.0 9.7  4.3
MDNS – 0.6  1.0 5.3  3.4
MNSI – 1.3  1.1 7.1  2.0
HbA1C – 8.1  1.7 7.2  1.7
Duration (months)
Diabetes – 76.9  71.8 69.9  52.4
Neuropathy – – 28.7  13.6
IENFD (fibers per mm)
Distal thigh 7.6  2.0 7.0  2.7 3.0  1.7
Distal leg 5.8  1.2 3.8  2.0 1.0  0.7
Results are means  SD. UENS, Utah early neuropathy scale; MDNS, Michigan diabetic neuropathy score; MNSI, Michigan neuropathy screening
instrument; HbA1C, glycosylated hemoglobin, hemoglobin A1c; IENFD, intraepidermal nerve fiber density.
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analysis. One-two images were removed from four control
patients’ thighs, two diabetic thighs, one diabetic leg, one
neuropathy thigh, and two neuropathy legs.
As with the image acquisition, images were masked
as to not influence the analysis. An imbedded selection
and cropping tool within Volocity software was used
to isolate the epidermis. The lower edge was cropped
precisely at the epidermal–dermal border, where a visible
change in the appearance of nerve, nuclei, and mitochon-
dria was observed. The upper edge was cropped to
exclude the stratum corneum where the rich mitochon-
dria, nerve, and nuclear stains were no longer present.
Image processing and deconvolution was performed using
Volocity in the same manner as described above under
methods for sensory neuron cultures. These images were
exported to Imaris for further analysis.
Imaris classification software made it possible to utilize
surfaces created from one fluorescent channel to isolate
fluorescent signals in another channel. Thus, the 3D ren-
dering of the nerve signal was used to isolate nerve-
specific mitochondrial signal within the nerve surface.
The nerve surfaces were created first with the “create
surface” tool to make a solid surface of the IENFs from
the AlexaFluor-488 fluorescent secondary labeling of the
PGP-9.5 identified nerves. The “smoothing” tool was not
used and absolute intensity was used to set the threshold
for the nerve signal since it was significantly brighter than
background fluorescence. Threshold was set to values low
enough to accurately mark the nerves. Any small, non-
nerve surfaces were filtered out based on size or were edi-
ted out from the “Edit” tab by selecting and deleting
them. Since we were only interested in the mitochondrial
staining within the nerves, we eliminated all of the mito-
chondrial staining outside the boundary of the nerve sur-
faces with the use of the Mask Properties options in the
Edit tab of the Nerve surface. The “mask all’ option was
used and the mask channel was set for the AlexaFlour-
594 fluorescent signal for mitochondria labeled with the
PDH antibody. The “duplicate channel before applying
mask” option was selected to preserve the original data,
and the mask option was chosen for “Set voxels outside
surface to 0.” This removed all mitochondrial signals
associated with the keratinocytes within the epithelium.37
The “create surface” tool was then used on the newly cre-
ated fluorescent channel of the nerve-specific mitochon-
drial signals that were isolated away from the
mitochondrial signal associated with epidermal cells. The
“smoothing” tool was not used and the background sub-
traction option was selected to use local contrast around
the mitochondrial signal to render surfaces around the
mitochondria. Threshold was set to values low enough to
accurately mark mitochondria. Tiny, non-mitochondrial
surfaces were filtered out based on size.
Values were exported from Imaris and into an Excel
spreadsheet for all nerve and mitochondrial surfaces. Sev-
eral measurements were collected and calculated for each
image: the size distribution of mitochondria in IENFs at
the DT and DL regions (placed in bins of increasing size),
the size distribution of mitochondria in the keratinocytes
of the DT, the number of mitochondria per IENF, and
the mitochondrial volume per IENF volume. These values
were used to compare between the groups.
Statistical analysis
All values are expressed as means  SEM. Prism software
(version 5.01; GraphPad Software Inc.) was used to deter-
mine the overall significance by analysis of variance
(ANOVA) and to identify differences between the groups
by Tukey’s post-hoc tests. Chi-square analysis was per-
formed using GraphPad Software’s QuickCalcs (www.
graphpad.com). Significance was defined as a P < 0.05.
Prism was used to plot all graphs.
Results
Visualization and quantification of
mitochondria within neurites of cultured
sensory neurons
Mitochondria within control DRG neurons and neurons
treated with elevated levels of glucose were imaged and
processed to create 3D surfaces around the neurite-spe-
cific mitochondrial signal to obtain volumetric measure-
ments (Fig. 1A–D). Quantification of mitochondrial
volume revealed a significantly greater proportion of
mitochondrial signal associated with larger volume ranges
after high glucose treatment (Fig. 1E). This 3D analysis
technique was used to examine nerve-specific mitochon-
drial signal in IENFs of human skin biopsies to determine
whether the observed hyperglycemic-induced changes in
mitochondria within neurites of cultured sensory neurons
translated clinically.
Visualization and quantification of
mitochondria within human IENFs
Immunofluorescence allowed for simultaneous labeling of
multiple signals within the human skin sections that
included nerves, mitochondria, and nuclei (Fig. 2A). Sig-
nals for nerves and mitochondria were optimized by
cropping out regions above and below the epidermis
(Fig. 2B). The first step in the analysis was to create 3D
surfaces around each nerve (Fig. 2C). The nerve surfaces
were then used to crop the nerve-specific fluorescent
mitochondrial signal (Fig. 2D). Finally, 3D surfaces were
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created around the nerve-specific mitochondrial signal to
obtain volumetric measurements (Fig. 2E).
Mitochondrial distribution in IENFs of the
DT
Patient identities were revealed only after all images were
processed for nerve and mitochondrial signals. The data
were separated into three groups; age-matched controls
(Control), diabetic patients (DM), and patients with
DPN. Representative 3D images taken with a 409 objec-
tive of DT tissue sections demonstrated a visible change
in the size distribution of mitochondrial surfaces in the
IENFs among the three groups (Fig. 3A–C). Quantifica-
tion of this change in distribution revealed a significant
shift (Chi-square 19.506, df, 7, P = 0.0067) in mitochon-
drial signal in DPN patients resulting in an increased
proportion of mitochondrial signal associated with larger
volumes (Fig. 3D). Images were taken with a 639 objec-
tive of corresponding 409 images to improve the resolution
of the mitochondrial signal. Side-by-side comparisons of
409 versus 639 (Fig. 4A and B) demonstrated a slight
improvement in resolution of the signals. Rendered
surface volumes of the IENF and mitochondrial signals
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Figure 1. Visualization and summary data for neurite-specific mitochondria within cultured rat dorsal root ganglia neurons grown in control or
elevated levels of glucose treatment media for 6 h. (A) Unprocessed image of control neuron illustrates the fluorescent labeling of mitochondria
(Mt, red). White box represents the magnified region displayed in (C). (B) Unprocessed image of glucose-treated neuron illustrates the fluorescent
labeling of mitochondria (Mt, red). White box represents the magnified region displayed in (D). (C and D) Mitochondrial surface renderings (Mt
surface, magenta) were created around neurite-specific mitochondrial signal in control and glucose-treated neurons using Imaris surface creation
tool. (E) Data presented as frequency histograms depicting the proportion of mitochondria binned according to size ranges of mitochondrial
signal volume (lm3). Glucose-treated neurons (black bars) had a significantly greater proportion of mitochondrial signal found in larger volume
ranges when compared to control neurons (white bars). Values represent means  SEM, *P < 0.0001, versus control group.
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from the 639 objective were all smaller than their corre-
sponding surfaces from 409. This was due to the
improved numerical aperture of the 639 objective (1.4
vs. 1.25). Despite the smaller volumes, the mitochondrial
surfaces appeared to be distributed in similar patterns
within the IENFs (Fig. 4C and D). The differences in the
frequency distribution of the mitochondrial signals taken
with the 639 objective were maintained among the three
patient groups (Fig. 4E). In particular, significant shifts in
mitochondrial signal size distributions were measured
Mt Surface
NerveNerve Mt
Nerve Surface
MtNerve Mt
A Nerve Nuc Mt
B C
D E
stratum corneum
dermis
epidermis
Nerve Nuc
Figure 2. Representative three-dimensional confocal microscopy image of a tissue section from a human epidermal biopsy. (A) Left panel shows
nerve (green) and nuclei (Nuc, blue) of keratinocytes within the epidermis. The middle panel is a schematic depicting the corresponding layers of
the stratum corneum, epidermis with keratinocytes, and dermis. The right panel includes staining for nerve (green), keratinocyte nuclei (Nuc,
blue), and mitochondria (Mt, red). (B) Unprocessed image illustrates the fluorescent labeling of nerve (green) and mitochondria (Mt, red) within
the cropped epidermis. White box in (B) represents the magnified region displayed in (D,E). (C) Surface renderings (Nerve Surface, cyan) were
created around the nerve signal using the Imaris surface creation tool. (D) Using nerve surfaces, nerve-specific mitochondrial signal (Mt, red) was
isolated from the red fluorescent channel. (E) The resulting nerve-specific fluorescent mitochondrial signal was used for further analysis to create
surfaces around mitochondria (Mt Surface, magenta). Scale bars = 20 lm.
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from both DM (Chi-square 20.89, df, 7, P = 0.0019) and
DPN patients (Chi-square 48.765, df, 7, P < 0.0001), with
more mitochondrial signal found within larger volume
ranges (Fig. 4E).
Mitochondrial distribution in keratinocytes
of the DT
To ensure that the change in mitochondrial size distribu-
tion was nerve specific, we also quantified mitochondrial
volumes from individual keratinocytes. The same surface
creation procedure was used to obtain keratinocyte-
specific mitochondrial volumes from the DT samples
(Fig. 5A). Unlike in the IENFs, no significant changes in
mitochondrial size distribution were observed between
controls and DM patients, or between controls and DPN
patients (Fig. 5B).
Comparison of mitochondrial distribution in
IENFs between DT and DL
Comparison between DT and DL biopsies was performed
in order to determine if there were length-dependent
differences in mitochondria within IENFs. Mitochondrial
volume within IENFs from DL biopsies was calculated for
images acquired with the 409 objective (Fig. 6A, C and
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Figure 3. Surface renderings that illustrate the distribution of mitochondria within distal thigh nerves and summary data for mitochondria within
intraepidermal nerve fibers of distal thigh from controls, diabetic patients, and patients with diabetic peripheral neuropathy. (A–C) Magnified
views of 3D surface renderings that depict nerve-specific mitochondria surfaces (Mt Surface, magenta) overlaid on fluorescent signal for nerves
(green). (A) Representative image of age-matched control tissue shows that nerves were fairly abundant in the distal thigh epidermis.
Mitochondria were distributed along the nerves. (B) Representative image of distal thigh tissue from a diabetic (DM) patient shows that nerves
were also fairly abundant with mitochondria. (C) Distal thigh tissue from patients with diabetic peripheral neuropathy (DPN) had reduced number
of nerves innervating the epidermis compared to control and diabetic subjects. These nerves were populated with larger sized mitochondrial
signals along the length of the nerves. Scale bars = 10 lm. (D) Data presented as frequency histograms depicting the proportion of nerve-specific
mitochondria binned according to mitochondrial volume (lm3). When all mitochondria were quantified, nerves from diabetic peripheral
neuropathy patients (DPN, black bars) exhibited a significant shift toward greater mitochondrial volumes compared to the control group. Values
represent means  SEM.
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Figure 4. Corresponding three-dimensional confocal microscopy images taken with either a 409 (A and C) or a 639 (B and D) objective of a
distal thigh tissue section from a control human epidermal biopsy. (A and B) Panels show fluorescent signals for nerve (green), nuclei (Nuc, blue),
and mitochondria (Mt, red). White box in (A) represents the area taken with the 639 objective in B. (C and D) Rendered mitochondrial signals
(Mt Surface, magenta) displayed with fluorescent nerve signals (Nerve, green) were distributed in similar patterns between the images taken with
the 409 and 639 objectives. Scale bars for A, B = 20 lm and C, D = 5 lm. (E) Data presented as frequency histograms depicting the proportion
of nerve-specific mitochondria binned according to mitochondrial volume (lm3) for the images taken with a 639 objective. When all
mitochondria were quantified, nerves from diabetic (DM, gray bars) and diabetic peripheral neuropathy patients (DPN, black bars) exhibited a
significant shift toward greater mitochondrial volumes compared to the control group. Values represent means  SEM.
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E) similar to the DT biopsies described above. There was
a significant (Chi-square 17.519, df, 7, P = 0.0143) change
in mitochondrial size distribution between the two biopsy
sites in the control group with more mitochondrial signal
associated with larger volumes in the DL than in the DT
(Fig. 6A). The length-dependent shift in mitochondrial
size distribution of the control group was not observed in
the DL of DM (Fig. 6C) or DPN patients (Fig. 6E).
Images taken with the 639 objective were also used to
compare nerve-specific mitochondrial signals between the
DT and DL (Fig. 6B, D and F). A similar shift toward lar-
ger mitochondrial volumes in the DL of control group
was measured in the 639 images (Fig. 6B). This shift was
also present in the DPN group at 639 (Fig. 6F).
Standard brightfield IENF density counts confirmed a
significant decrease in innervation in the DT (P < 0.001)
as well as the DL (P < 0.0001) of DPN patients (Fig. 7A).
There was no significant change in the average number of
mitochondria per nerve volume across the three patient
groups at either the DT or the DL (Fig. 7B). The percent
of mitochondrial surface volume per total nerve surface
volume was not significantly different among the three
groups, although there was a slight increase in the DM
and DPN groups compared to controls in both the DT
and DL. Higher percentage of mitochondrial volume per
nerve volume was measured in the DL compared to the
DT (Fig. 7C).
Discussion
Our laboratory and others have focused on alterations in
mitochondria as a possible mechanism for neuro-
pathy.23,27–29,31–33 A recent study examined the role of
mitochondria in small fiber neuropathy, focusing on the
mitochondria in subepidermal nerve fibers using a 2D
analysis method that relied on the colocalization of nerve
and mitochondrial signal for quantification.38 Our study
is the first to 3D visualize and quantify changes in mito-
chondrial distribution within IENFs in man.
Visualization and quantification of
mitochondria within neurites of cultured
sensory neurons and human IENFs
The combination of fluorescence immunohistochemistry,
confocal microscopy, and 3D image analysis allowed for
the visualization and measurement of the distribution of
mitochondria within neurites and IENFs. The technique
was initially developed in an in vitro model system to
quantify hyperglycemia-induced changes in the size distri-
bution of mitochondria within neurites of sensory neu-
rons. We then applied this technique to biopsies from
diabetic patients and demonstrated that patients with
diabetes and DPN have a measureable change in mito-
chondria distribution within their IENFs compared to
age-matched controls.
Proportion of mitochondrial signal
associated with larger volumes was
increased in DT IENFs of patients with DPN
IENFs in the DT showed a disease-induced change in
mitochondrial size distribution. DPN patients had an
increased volumetric proportion of mitochondria in their
IENFs compared to age-matched control subjects. Inter-
estingly, corresponding higher resolution images (639,
numerical aperture 1.4) of a subset of the data taken with
the 409 objective demonstrated a similar shift toward lar-
ger mitochondrial volumes in the DPN group as well as
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Figure 5. Visualization and summary data of mitochondria within
epidermal keratinocytes of distal thigh from controls, diabetic
patients, and patients with diabetic peripheral neuropathy. (A) Image
from a control patient illustrates the fluorescent labeling of
mitochondria (Mt, red) and the mitochondria surfaces created within
keratinocytes (Mt Surface, magenta). Image also shows nerve-specific
mitochondria surface used in a separate analysis. (B) Data presented
as frequency histograms depicting the proportion of keratinocyte-
specific mitochondria binned according to appropriate ranges based
on mitochondrial volume (lm3). There was no significant difference in
the volume distribution of keratinocyte mitochondria of diabetic (DM,
gray bars) nor diabetic peripheral neuropathy (DPN, black bars)
patients when compared to controls (white bars). Values represent
means  SEM scale bar 10 lm.
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the DM group. This suggests that neuropathy could result
in increased mitochondria within these nerves.31 The
absence of a similar trend in the keratinocytes from the
same samples indicates that this is a nerve-specific phe-
nomenon, and may be associated with neuropathy. A
similar increase in mitochondrial signal has been reported
after 30-day treatment with mitotoxic linezolid, an antibi-
otic known to produce sensory peripheral neuropathy.38
Changes in mitochondria size distribution in IENFs of
the DT might be due to changes in mitochondrial
dynamics such as fission, fusion, or trafficking. Our group
and others have shown diabetes and neuropathy-induced
changes in the fission/fusion machinery of sensory neu-
rons.28,31,39 It is possible that our observed larger mito-
chondrial signals could be composed of clusters of
smaller, potentially dysfunctional mitochondria that have
gone through aberrant fission, or of larger predegenera-
tive, swollen mitochondria.40–43 In support of this, recent
work from our group observed axonal swelling associated
with IENFs of patients with diabetic neuropathic pain.44
It is possible that mitochondrial and axonal swellings are
associated with changes in sensory nerve function. Despite
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Figure 6. Summary data for mitochondria within intraepidermal nerve fibers of distal thigh compared to distal leg from controls, diabetic
patients, and patients with diabetic peripheral neuropathy. Data presented as frequency histograms depicting the proportion of nerve-specific
mitochondria binned to mitochondrial volume (lm3). Analysis of images taken with a 409 objective (A,C and E) were compared to images taken
with a 639 objective (B, D, and F). In the control group, distal leg (white hashed bars) samples contained a significantly greater proportion of
mitochondria found in larger volume ranges when compared to distal thigh (white solid bars) in both the 409 (A) and 639 images (B). The
increased mitochondrial size was not observed in the distal leg (hashed bars) of diabetic patients (DM, gray bars) at either 409 (C) or 639 (D) nor
was it shown in the neuropathy (DPN, black hatched bars) patients at 409 (E). A significant shift toward larger mitochondrial volumes was
observed in the distal leg (black hashed bars) of DPN patients compared to distal thigh (black bars) when analyzed from images taken with a 639
objective (F). Values represent means  SEM. n.s., not significant.
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an attempt to image at a higher resolution with a 639
objective, the mitochondrial signal was not resolved sig-
nificantly better than with a 409 objective. Further stud-
ies at the electron microscopy level will be necessary to
resolve these issues.
Another possibility is that larger mitochondrial signals
are the result of a disruption in axonal transport, result-
ing in aggregation or clustering of mitochondria, or fail-
ure of larger, swollen mitochondria to transport
compared to smaller mitochondria.45,46 Dysfunction in
mitochondrial transport contributes to a variety of neuro-
degenerative diseases.47–53 The trafficking and docking of
mitochondria are crucial for normal nerve function54–57
and our findings and others23,26 suggest a potential role
of mitochondrial dynamics in the development or pro-
gression of peripheral neuropathy.
Distal Thigh Distal Leg
IENF Densities
Number of Mitochondria per Nerve Volume
Mitochondrial Volume per Nerve Volume
B
A
C
Control DM DPN
0
2
4
6
8
10 Distal Thigh
IE
N
F 
D
en
si
ty
 C
ou
nt
s
(fi
be
rs
/m
m
)
*
Control DM DPN
0
2
4
6
8
10 Distal Leg
*
Control DM DPN
0
10
20
30
N
um
be
r o
f M
ito
ch
on
dr
ia
 p
er
N
er
ve
 V
ol
um
e 
(#
 / 
10
0
m
3 )
*
Control DM DPN
0
10
20
30
*
Control DM DPN
0
5
10
15
20
Pe
rc
en
t M
ito
ch
on
dr
ia
l V
ol
um
e
 p
er
 T
ot
al
 N
er
ve
 V
ol
um
e 
(
m
3 )
Control DM DPN
0
5
10
15
20
*
Figure 7. Summary data for intraepidermal nerve fiber density (IENFD), mitochondrial counts, and volumetric proportion of mitochondria in IENFs
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Neither diabetes nor DPN significantly
altered mitochondria distribution within
IENFs of the DL
A well-known characteristic of DPN is the length-depen-
dent loss of sensation.58 Therefore, mitochondrial signals
in IENFs were compared between the DT and DL of all
three patient populations. A length-dependent shift
toward larger mitochondrial volumes was measured in
the DL compared to the DT of the control group. Analy-
sis of the mitochondria from images taken at higher reso-
lution (639 objective) also supported the length-
dependent shift in the control group. This length-depen-
dent difference was not observed in the DM and DPN
groups in images taken with a 409 objective. However, a
shift toward larger mitochondrial volumes was shown in
the DL of the DPN group from images taken at the
higher resolution. Higher proportions of large mitochon-
drial volumes in the DL IENFs suggest that mitochondria
in these distal nerves are distributed in a similar way to
the compromised nerves in the thigh of DPN patients.
The shift toward larger mitochondrial volumes distally
might support an increased vulnerability of DL IENFs
that would make them more susceptible to abnormal
mitochondrial functions such as oxidative stress induced
by hyperglycemia and diabetes.28,59
DT may provide a better region to monitor
the effectiveness of therapeutics designed
to improve or prevent DPN
The IENFs from the DT showed a differential distribution
of mitochondria that is associated with DPN. An increase
in mitochondrial aggregates may be a potential mecha-
nism for increased susceptibility for poor nerve fiber
function, potential degeneration, or poor regeneration
upon injury. In support of this, DPN subjects showed a
slower regeneration of DT IENFs than their control coun-
terparts in response to capsaicin-induced denervation.13
We too have shown that the DT is a better indicator of
the beneficial effects of diet and exercise counseling by
measuring increased IENF densities after such lifestyle
intervention.13,17 The results of our study suggest that the
DT would be a better region to assess the effects of thera-
peutic interventions designed to lessen or reverse the pro-
gression of sensory loss associated with DPN. Future
studies might benefit using biopsies from the thigh to
study changes in mitochondria distribution in IENFs
instead of biopsies from the DL.
In summary, we developed an optical technique to spe-
cifically image and quantify nerve mitochondria in the
epidermis while excluding mitochondria from other cell
sources, such as skin keratinocytes. The results of this
study support the hypothesis that altered mitochondrial
dynamics may contribute to DPN pathogenesis. These
findings provide insight into future research designed to
elucidate potential therapeutic interventions directed at
regulating mitochondrial networks that may ultimately
alleviate or prevent DPN.
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